Evidence map›Paper›PMID 15517155›Full record

Trial reportDer Orthopade2005

[In vitro effects of diclofenac and selective cyclooxygenase-2 inhibitors on prostaglandin release from inflamed bursa subacromialis tissue in patients with subacromial syndrome].

H Knorth, R H Wittenberg, P Dorfmüller, R Lebert, W E Schmidt, B M Peskar, M Wiese, M Heukamp, R E Willburger

Abstract readClinical TrialEnglish Abstract
PubMed Publisher
In one paragraph

Trial report in Der Orthopade, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

H KnorthAbteilung für Rheumaorthopädie im St. Elisabeth-Hospital, Orthopädische Universitätsklinik der Ruhr-Universität Bochum.
R H Wittenberg
P Dorfmüller
R Lebert
W E Schmidt
B M Peskar
M Wiese
M Heukamp
R E Willburger
Orthopädische Universitätsklinik · DERuhr University Bochum · DESt. Elisabeth-Hospital Bochum · DESt. Josef-Hospital · DELWL-Universitätsklinik Hamm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo compare the in vitro effects of selective COX-2 inhibitors (L-745,337, NS-398 and DFU) and of COX-unspecific diclofenac on release of PGE(2 )and 6-keto-PGF(1alpha) from inflamed bursa subacromialis tissue (IBST) obtained from a total of 35 patients with shoulder impingement syndrome (SIS). PATIENTS AND

methodsBursal specimens were incubated in the presence of drugs (0.01-1000 microM) for 20 min and 16 h.

resultsAfter 20 min 10 microM diclofenac significantly inhibited formation of PGE(2) and 6-keto-PGF(1alpha), whereas L-745,337 and NS-398 (10-1000 microM) induced significant inhibition only at concentrations > or =100 microM. In contrast to equimolar diclofenac, DFU (0.01-10 microM) induced no inhibition of bursal PGE(2) release but a dose-dependent, although statistically not significant inhibition after 16 h. The inhibitory potency of diclofenac (0.01-10 microM) was even more increased during long-term incubation showing greater inhibition than DFU at all concentrations studied.

conclusionThe data suggest that in IBST in SIS in vitro the majority of PG is generated via the COX-1 pathway.

Indexed as

AcromionAdultAgedAnti-Inflammatory Agents, Non-SteroidalBursitisCyclooxygenase 2 InhibitorsDiclofenacFemaleHumansMaleMiddle AgedProstaglandinsShoulder Impingement SyndromeAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsDiclofenacProstaglandins

Identifiers

PMID15517155
OpenAlexW210806760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.